Xeris Biopharma Holdings
XERS
XERS
120 hedge funds and large institutions have $144M invested in Xeris Biopharma Holdings in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 12 closing their positions.
Holders
120
Holders Change
+10
Holders Change %
+9.09%
% of All Funds
1.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
22
Increased
37
Reduced
31
Closed
12
Calls
$1.95M
Puts
$190K
Net Calls
+$1.76M
Net Calls Change
+$163K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$5.74M |
| 2 |
2
BlackRock
New York
|
$23.5M |
| 3 |
ICM
3
Invenomic Capital Management
Boston,
Massachusetts
|
$1.34M |
| 4 |
DMKJ
4
David M. Knott Jr
|
$912K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$941K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Verition Fund Management
Greenwich,
Connecticut
| – | -$45.9K | -24,700 | Closed |
|
|
BFG
127
Bleakley Financial Group
Fairfield,
New Jersey
| – | -$20.5K | -11,048 | Closed |
|
|
SS
128
Simplicity Solutions
Minneapolis,
Minnesota
| – | -$20.5K | -11,048 | Closed |
|
|
AIM
129
Aigen Investment Management
New York
| – | -$19.3K | -10,384 | Closed |
|
130
Russell Investments Group
London,
United Kingdom
| – | -$221 | -119 | Closed |
|
|
CSS
131
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$177 | -95 | Closed |
|